1. Morrc M, Coude FX, Diaz J, Roncucci R. Therapeutic potential of GRF: first biological results, pp. 335–341 In « Therapeutic agents produced by genetic engineering: Quo Vadis ? The example of growth hormone and its releasing factor ». A. Joyeaux, G. Leygue, M. Morrc, R. Roncucci, PH. Schmelck, Ed. « Quo Vadis ? » Symosium-Sanofi Group-May 29–30, 1985-Toulouse-Labege, France.
2. Fleischer N, Guillemin R.In: Parsons JA Ed. Peptide Hormones. Macmillan Press, i London 1976, pp. 317–32.
3. Wahren J, Fclig P. Influence of somatostai tin on carbohydrate disposal and absorption in diabetes mellitus.Lancet.1976, 2, 1213.
4. Somerville KW, Davies JG, Hawkey CJ, Henry DA, Hine KR, Langman MJS. Somatostatin in treatment of hacmatemesis and melaena.Lancet.1985, 1, 130–2.